CompaniesAfexa Life Sciences

Afexa Life Sciences

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (6)
View all

Total Trials

6

As Lead Sponsor

5

As Collaborator

1

Total Enrollment

1,330

By Phase

PHASE1: 3PHASE2: 2PHASE3: 1

By Status

COMPLETED: 4WITHDRAWN: 1TERMINATED: 1
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
Today
NCT00240461
NCT00726401
NCT00965822
NCT00966225
Hover over trial bars to see details

Recent Trials

NCT01456182Lead Sponsor
Phase 1B- Open Label Dose-Ranging Study of Oral AFX-2 in Adults With Chronic Lymphocytic Leukemia
PHASE1Withdrawn
Started: Dec 31, 2011 · Completed: May 31, 2013
NCT01468376Lead Sponsor
GLU-xx Formulations in Individuals With Impaired Glucose Tolerance
PHASE1Terminated
17 participants
Started: Feb 28, 2011 · Completed: Jan 31, 2012
NCT00965822Lead Sponsor
A Randomized, Double-blind, Placebo-controlled Study on the Efficacy and Safety of CVT-E002 in the Treatment of Upper Respiratory Tract Infections in a Pediatric (3-11 Years) Population
PHASE2Completed
293 participants
Started: Sep 30, 2009 · Completed: Apr 30, 2012
NCT00966225Lead Sponsor
LIP-01 in Hypercholesterolemia
PHASE1Completed
40 participants
Started: Sep 30, 2009 · Completed: Jan 31, 2012
NCT00726401Lead Sponsor
A Randomized, Double-blind, Placebo-controlled Study on the Effect of CVT-E002 in Patients With Seasonal Allergic Rhinitis
PHASE2Completed
200 participants
Started: May 31, 2008 · Completed: Sep 30, 2010
View all 6 trials →
Related Companies
Valeant Oct 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired
Afexa Life Sciences | Biotech Hunter | Biotech Hunter